Universal Ibogaine Targets Fundraising for Clinical Trials

Universal Ibogaine Inc (TSE:IBO) has released an update.

Universal Ibogaine Inc. is set to raise $350,000 through a private placement offering of common shares, aimed at financing its ibogaine-based clinical trial application with Health Canada and for general working capital. Following the approval at the annual meeting of shareholders, the company re-elected its board members, appointed MNP LLP as auditors, and approved its 2024 Employee Equity Incentives Plan and Stock Option Plan.

For further insights into TSE:IBO stock, check out TipRanks’ Stock Analysis page.